23491-48-7

Basic information

• Product Name: 5-(4-Methylpiperazin-1-yl)-2-nitroaniline
• Synonyms: BUTTPARK 17\04-69;BENZENAMINE, 5-(4-METHYL-1-PIPERAZINYL)-2-NITRO-;5-(4-METHYL-PIPERAZIN-1-YL)-2-NITROANILINE;5-(4-METHYLPIPERAZIN-1-YL)-2-NITROPHENYLAMINE;5-(4-METHYLPIPERAZINO)-2-NITROANILINE;5-(4-Methyl-1-piperazinyl)-2-nitroaniline;5-(4-Methylpiperazino)-2-Nitro;1-(3-Amino-4-nitrophenyl)-4-methylpiperazine
• CAS NO: 23491-48-7
• Molecular Formula: C₁₁H₁₆N₄O₂
• Molecular Weight: 236.27
• Product Categories: API intermediates;Piperazidine intermediates;Piperazines
• Mol File: 23491-48-7.mol
• Article Data: 52

Chemical Properties

• Melting Point: 152-155°C
• Boiling Point: 444.2 °C at 760 mmHg
• Flash Point: 222.4 °C
• Appearance: /
• Density: 1.264 g/cm³
• Vapor Pressure: 4.37E-08mmHg at 25°C
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• PKA: 7.35±0.42(Predicted)
• CAS DataBase Reference: 5-(4-Methylpiperazin-1-yl)-2-nitroaniline(CAS DataBase Reference)
• NIST Chemistry Reference: 5-(4-Methylpiperazin-1-yl)-2-nitroaniline(23491-48-7)
• EPA Substance Registry System: 5-(4-Methylpiperazin-1-yl)-2-nitroaniline(23491-48-7)

Safety Data

• Hazard Codes: Xi
• Safety Statements: 24/25
• HazardClass: IRRITANT
• Hazardous Substances Data: 23491-48-7(Hazardous Substances Data)

Usage

Chemical Properties

Solid

InChI:InChI=1/C11H16N4O2/c1-13-4-6-14(7-5-13)9-2-3-11(15(16)17)10(12)8-9/h2-3,8H,4-7,12H2,1H3/p+1

Upstream product

• 109-01-3 1-methyl-piperazine 
• 1635-61-6 5-chloro-2-nitroaniline 
• 20289-35-4 5-iodo-2-nitro-aniline 
• 2369-11-1 5-fluoro-2-nitroaniline 
• 68-12-2 N,N-dimethyl-formamide 

Downstream Products

• 129244-58-2 2-(3,5-di-tert-butyl-4-hydroxybenzyl)-5⁽⁶⁾-(4-methyl-1-piperazinyl)benzimidazole 
• 129244-61-7 2-(3,5-di-tert-butyl-4-hydroxyphenethyl)-5⁽⁶⁾-(4-methyl-1-piperazinyl)benzimidazole 
• 129244-66-2 2-<2-(3,5-di-tert-butyl-4-hydroxyphenyl)-5'(6')-benzimidazolyl>-5(6)-<1-(4-methylpiperazinyl)>benzimidazole 
• 129244-67-3 2-<2-(3,5-di-tert-butyl-4-hydroxybenzyl)-5'(6')-benzimidazolyl>-5(6)-<1-(4-methylpiperazinyl)>benzimidazole 
• 129244-68-4 2-<2-(3,5-di-tert-butyl-4-hydroxyphenethyl)-5'(6')-benzimidazolyl>-5(6)-<1-(4-methylpiperazinyl)>benzimidazole 
• 23623-05-4 4-[5'-(4'-methylpiperazin-1'-yl)benzimidazol-2'-yl]-2-nitroaniline 
• 23491-49-8 4-<5'-(4''-methylpiperazin-1''-yl)benzimidazol-2'-yl>benzene-1,2-diamine 

Relevant articles and documents

A new strategy for site-specific alkylation of DNA using oligonucleotides containing an abasic site and alkylating probes

Selective chemical reactions with DNA, such as its labelling, are very useful in many applications. In this paper, we discuss a new strategy for the selective alkylation of DNA using an oligonucleotide containing an abasic site and alkylating probes. We d

Di-(benzimidazole)-1, 2, 3-triazole derivative as well as preparation and application thereof in inflammatory dermatosis

The invention belongs to the technical field of drug small molecules, and particularly discloses a brand-new di-(benzimidazole)-1, 2, 3-triazole derivative as well as preparation and application of the brand-new di-(benzimidazole)-1, 2, 3-triazole derivative. The research finds that the brand new compound has an excellent drug effect and low toxic and side effects on the aspect of inflammatory dermatosis, and has a good application prospect in the aspect of drug development of the inflammatory dermatosis.

Pyrazole spleen tyrosine kinase inhibitor as well as preparation method and application thereof

The invention discloses a pyrazole spleen tyrosine kinase inhibitor, a preparation method thereof, a pharmaceutical composition containing the same, and application of the pyrazole spleen tyrosine kinase inhibitor and the pharmaceutical composition in the preparation of drugs for treating Syk-mediated diseases including cancers, inflammatory diseases and the like.